Atropine eye drops to slow nearsightedness after cataract surgery in children
Part of Blood & lymphatic, Cancer, Eyes & vision, Immune system & allergy clinical trials.
This trial tests whether atropine eye drops can slow down nearsightedness (myopia) that often happens after cataract surgery in young children. If your child is eligible, they will receive the drops to help keep their vision from getting worse.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child had cataract surgery with a lens implant (this can be at the time of surgery or later).
- Your child is between 1 and 7 years old.
- Your child does not have other eye conditions like retinal disease or glaucoma.
- There were no major problems during cataract surgery.
- Your child's eyes are clear enough for the doctor to check their vision.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether daily atropine eye drops can slow down worsening nearsightedness in children. It's for kids aged 5–10 whose myopia is actively progressing.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
This trial tests whether atropine eye drops can reduce the progression of myopia (nearsightedness, where you have trouble seeing far away) in children. It might help slow down the worsening of vision over time.
This study tests whether low-dose atropine eye drops can prevent nearsightedness (myopia) in children. Atropine is a medicine that has been used to slow myopia, and this trial looks at gradually increasing the dose to find the best approach.
This study tests if low-dose atropine eye drops can slow down worsening nearsightedness in children. Children in the study receive either the drops or no treatment, and their vision changes are tracked over time.
This trial studies using low-dose atropine eye drops to help slow worsening nearsightedness (myopia) in children. It may help kids whose myopia is actively getting worse, depending on how consistently the drops are used.
Hear when a new Pediatric Cataract trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.